Following an extensive search of industry and academic professionals by The Chase Group, the Allen Institute for Immunology welcomes a new Director, Informatics & Computational…
Continue Reading →
After a comprehensive executive search that was filled in less than two months, The Chase Group is pleased to announce the placement of Carla Poulson…
Continue Reading →
As a result of their partnership with The Chase Group, Genmab has secured a Director, Global Drug Safety and Pharmacovigilance Physician for their team in…
Continue Reading →
Due to their long-standing relationship, Checkmate’s Chief Medical Officer has again partnered with The Chase Group as he builds his clinical team. Founded in 2015…
Continue Reading →
Akcea Therapeutics is driven by determination and focus on addressing the unmet needs and complex medical challenges of patients with serious and rare disorders. As…
Continue Reading →
The Chase Group is proud to partner with Eli Lilly and support their commitment to developing innovative, breakthrough medicines that will make a meaningful difference…
Continue Reading →
Eisai, Inc.’s partnership with Merck has proven to be successful with the FDA approval of the Keytruda and Lenvima Combination Treatment. With 13 indications for…
Continue Reading →
Due to their long-standing relationship, Checkmate’s Chief Medical Officer has again partnered with The Chase Group as he builds his clinical team. Founded in 2015…
Continue Reading →
The Chase Group is excited to reengage partnership with Akcea Therapeutics to recruit the company’s Vice President of Human Resources. The Vice President will lead…
Continue Reading →
The Chase Group has been retained by Genmab in Copenhagen, Denmark, to continue building their drug safety team and is recruiting to secure a Director,…
Continue Reading →